Phase II Randomised Controlled Trial of Patient-specific Adaptive vs. Continuous Abiraterone or eNZalutamide in mCRPC
Clinical trial NCT05393791 · RECRUITING
Trial details
- NCT number
- NCT05393791
- Sponsor
- Leiden University Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-10
- Primary completion
- 2027-11-10
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.